Anwita Biosciences
Clinical trials sponsored by Anwita Biosciences, explained in plain language.
-
Experimental biologic AWT020 put to the test in Hard-to-Treat cancers
Disease control Recruiting nowResearchers are testing an experimental biologic called AWT020 in adults with advanced solid tumors that have worsened after at least one standard treatment. The phase 1 trial gives AWT020 every three weeks at increasing dose levels to find the highest dose people can tolerate an…
Phase 1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cancer drug AWT020 enters first human trial
Disease control Recruiting nowThis early-phase trial is testing a new biologic drug called AWT020 in 60 adults with advanced solid tumors or lymphoma that have worsened after standard treatments. The main goals are to check the drug's safety at different doses and to see how the body processes it. Participant…
Phase 1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC